drugset / Trial / NCT01872780

Identification of Null Allelic Variant of CYP2C8 In A Korean Population

NCT01872780

Phase 1 Completed 11 enrolled Inje University
Non-randomizedParallel-groupOpen-labelBasic science

Summary

The genotype profile of CYP2C8 was analyzed in a Korean population. Frequency in multi-ethnic population and in vivo functionality of novel null allelic CYP2C8 variant were evaluated.

Timeline

Start
2008-08
Primary completion
2009-02
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Rosiglitazone Small molecule 4 mg Oral

Indications

No indication recorded.